Pharmaceutical Business Review
Anonymous User | Login

Health Canada Accepts EpiCept's Ceplene Application For Review

Published: 09-Nov-2009

Ceplene, approved in the EU for the remission maintenance and prevention of relapse in patients with AML

The Health Canada has accepted for review EpiCept's New Drug Submission (NDS) for Ceplene (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first complete remission. Health Canada’s performance target for the completion of review and a decision is within 300 days.

Ceplene is approved in the EU for the remission maintenance and prevention of relapse in patients with AML in first remission. The company is continuing negotiations with prospective partners for the European marketing rights to Ceplene.

The company also announced that Israel’s Ministry of Health has accepted a marketing application for Ceplene for the remission maintenance of AML patients in first remission. The company’s distribution and marketing partner for Ceplene in Israel, Megapharm has filed the application and will market Ceplene upon approval. A decision on this application is anticipated late next year.

Jack Talley, president and CEO of EpiCept, said: "We are pleased to have completed another key milestone in our North American regulatory strategy for Ceplene, as the next step in this process, we are focused on the filing of a New Drug Application for Ceplene with the FDA for AML remission maintenance. As previously stated, we intend to utilize the approval of Ceplene in order to establish a fully integrated specialty pharmaceutical company focused in hematology in North America."

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

Farmalyse

Laboratory Contract Services ...

ikfe CRO

Diabetes and Cardiovascular Research ...

LORENZ

Life Sciences Group ...

Axiom Real Time Metrics

EDC Solutions ...

EXTEDO

Key Services and Solutions Provider ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GRACO's New FDA Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New Hydra-Clean

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New 1590 & 3150 Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Customer Testimonial – Astra Zeneca

From the control room to the downstream processing area and with an eye on utilities servi ...

Hygienic Processing

From the control room to the downstream processing area and with an eye on utilities servi ...

Related Companies

EpiCept Corporation

EpiCept Corporation (EpiCept) is a pharmaceutical company, engaged in development and c ...

Genta Incorporated

Genta Incorporated (Genta) is a biopharmaceutical company engaged the discovery, develo ...

Pfizer Inc.

Pfizer Inc. (Pfizer) is a global research based pharmaceutical company principally focu ...

Purdue Pharma L.P.

Purdue Pharma L.P. (Purdue) is a privately held pharmaceutical company. It is principal ...

Anesiva, Inc.

Anesiva, Inc. (Anesiva) is a biopharmaceutical company, engaged in the research, develo ...

Suppliers Product News

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

LORENZ Launches eValidator 3.0 - Basic Free and Professional Versions

LORENZ today announced the release of version 3.0 of its popular eValidator validation tool. The name change from eCTD Validator reflects the broader validation scope the tool has received in this major upgrade.

LORENZ Wins Tender to Supply eCTD Review System to Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products

LORENZ Life Sciences Group, the largest supplier of eCTDs in the world, announced today that it has won the tender to supply an eCTD review system to the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address